The global market for Multi-Organ-on-a-Chip Models was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Multi-Organ-on-a-Chip Model uses micro-processing technology to produce a bionic system that can simulate the main functions of multiple human organs on a microfluidic chip. Multi-Organ-on-a-Chip can construct multiple organs in different functional areas at the same time and connect them through chip pipelines.
North American market for Multi-Organ-on-a-Chip Models is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Multi-Organ-on-a-Chip Models is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Multi-Organ-on-a-Chip Models in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Multi-Organ-on-a-Chip Models include Mimetas, TissUse, CN Bio Innovations, Hesperos, AxoSim, Elvesys, Beijing Abace Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Multi-Organ-on-a-Chip Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-Organ-on-a-Chip Models.
The Multi-Organ-on-a-Chip Models market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multi-Organ-on-a-Chip Models market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi-Organ-on-a-Chip Models companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mimetas
TissUse
CN Bio Innovations
Hesperos
AxoSim
Elvesys
Beijing Abace Biotechnology
Segment by Type
Gut/Liver-on-a-chip Model
Lung/Liver-on-a-chip Model
Nerve/Muscle-on-a-chip Model
Heart/Liver-on-a-chip Model
Others
Segment by Application
Pharmaceutical
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi-Organ-on-a-Chip Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi-Organ-on-a-Chip Models Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gut/Liver-on-a-chip Model
1.2.3 Lung/Liver-on-a-chip Model
1.2.4 Nerve/Muscle-on-a-chip Model
1.2.5 Heart/Liver-on-a-chip Model
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multi-Organ-on-a-Chip Models Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi-Organ-on-a-Chip Models Market Perspective (2020-2031)
2.2 Global Multi-Organ-on-a-Chip Models Growth Trends by Region
2.2.1 Global Multi-Organ-on-a-Chip Models Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multi-Organ-on-a-Chip Models Historic Market Size by Region (2020-2025)
2.2.3 Multi-Organ-on-a-Chip Models Forecasted Market Size by Region (2026-2031)
2.3 Multi-Organ-on-a-Chip Models Market Dynamics
2.3.1 Multi-Organ-on-a-Chip Models Industry Trends
2.3.2 Multi-Organ-on-a-Chip Models Market Drivers
2.3.3 Multi-Organ-on-a-Chip Models Market Challenges
2.3.4 Multi-Organ-on-a-Chip Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi-Organ-on-a-Chip Models Players by Revenue
3.1.1 Global Top Multi-Organ-on-a-Chip Models Players by Revenue (2020-2025)
3.1.2 Global Multi-Organ-on-a-Chip Models Revenue Market Share by Players (2020-2025)
3.2 Global Multi-Organ-on-a-Chip Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multi-Organ-on-a-Chip Models Revenue
3.4 Global Multi-Organ-on-a-Chip Models Market Concentration Ratio
3.4.1 Global Multi-Organ-on-a-Chip Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-Organ-on-a-Chip Models Revenue in 2024
3.5 Global Key Players of Multi-Organ-on-a-Chip Models Head office and Area Served
3.6 Global Key Players of Multi-Organ-on-a-Chip Models, Product and Application
3.7 Global Key Players of Multi-Organ-on-a-Chip Models, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi-Organ-on-a-Chip Models Breakdown Data by Type
4.1 Global Multi-Organ-on-a-Chip Models Historic Market Size by Type (2020-2025)
4.2 Global Multi-Organ-on-a-Chip Models Forecasted Market Size by Type (2026-2031)
5 Multi-Organ-on-a-Chip Models Breakdown Data by Application
5.1 Global Multi-Organ-on-a-Chip Models Historic Market Size by Application (2020-2025)
5.2 Global Multi-Organ-on-a-Chip Models Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multi-Organ-on-a-Chip Models Market Size (2020-2031)
6.2 North America Multi-Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multi-Organ-on-a-Chip Models Market Size by Country (2020-2025)
6.4 North America Multi-Organ-on-a-Chip Models Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi-Organ-on-a-Chip Models Market Size (2020-2031)
7.2 Europe Multi-Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multi-Organ-on-a-Chip Models Market Size by Country (2020-2025)
7.4 Europe Multi-Organ-on-a-Chip Models Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi-Organ-on-a-Chip Models Market Size (2020-2031)
8.2 Asia-Pacific Multi-Organ-on-a-Chip Models Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multi-Organ-on-a-Chip Models Market Size by Region (2020-2025)
8.4 Asia-Pacific Multi-Organ-on-a-Chip Models Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi-Organ-on-a-Chip Models Market Size (2020-2031)
9.2 Latin America Multi-Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multi-Organ-on-a-Chip Models Market Size by Country (2020-2025)
9.4 Latin America Multi-Organ-on-a-Chip Models Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi-Organ-on-a-Chip Models Market Size (2020-2031)
10.2 Middle East & Africa Multi-Organ-on-a-Chip Models Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multi-Organ-on-a-Chip Models Market Size by Country (2020-2025)
10.4 Middle East & Africa Multi-Organ-on-a-Chip Models Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mimetas
11.1.1 Mimetas Company Details
11.1.2 Mimetas Business Overview
11.1.3 Mimetas Multi-Organ-on-a-Chip Models Introduction
11.1.4 Mimetas Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.1.5 Mimetas Recent Development
11.2 TissUse
11.2.1 TissUse Company Details
11.2.2 TissUse Business Overview
11.2.3 TissUse Multi-Organ-on-a-Chip Models Introduction
11.2.4 TissUse Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.2.5 TissUse Recent Development
11.3 CN Bio Innovations
11.3.1 CN Bio Innovations Company Details
11.3.2 CN Bio Innovations Business Overview
11.3.3 CN Bio Innovations Multi-Organ-on-a-Chip Models Introduction
11.3.4 CN Bio Innovations Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.3.5 CN Bio Innovations Recent Development
11.4 Hesperos
11.4.1 Hesperos Company Details
11.4.2 Hesperos Business Overview
11.4.3 Hesperos Multi-Organ-on-a-Chip Models Introduction
11.4.4 Hesperos Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.4.5 Hesperos Recent Development
11.5 AxoSim
11.5.1 AxoSim Company Details
11.5.2 AxoSim Business Overview
11.5.3 AxoSim Multi-Organ-on-a-Chip Models Introduction
11.5.4 AxoSim Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.5.5 AxoSim Recent Development
11.6 Elvesys
11.6.1 Elvesys Company Details
11.6.2 Elvesys Business Overview
11.6.3 Elvesys Multi-Organ-on-a-Chip Models Introduction
11.6.4 Elvesys Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.6.5 Elvesys Recent Development
11.7 Beijing Abace Biotechnology
11.7.1 Beijing Abace Biotechnology Company Details
11.7.2 Beijing Abace Biotechnology Business Overview
11.7.3 Beijing Abace Biotechnology Multi-Organ-on-a-Chip Models Introduction
11.7.4 Beijing Abace Biotechnology Revenue in Multi-Organ-on-a-Chip Models Business (2020-2025)
11.7.5 Beijing Abace Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Mimetas
TissUse
CN Bio Innovations
Hesperos
AxoSim
Elvesys
Beijing Abace Biotechnology
听
听
*If Applicable.
